Evidence map›Paper›PMID 28082471›Full record

Observational studyEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2017

Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.

Anders S I Andreasson, Danai M Karamanou, Colin S Gillespie, Faruk Özalp, Tanveer Butt, Paul Hill, Kasim Jiwa, Hannah R Walden, Nicola J Green, Lee A Borthwick and 7 more

Abstract readObservational Study
In one paragraph

Observational study in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Research advances in consistency and variability inJournal of thoracic disease · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. MG53 mitigates warm ischemic lung injury in a murine model of transplantation.The Journal of thoracic and cardiovascular surgery · 2024
    Article
  8. Mitsugumin 53 mitigation of ischemia-reperfusion injury in a mouse model.The Journal of thoracic and cardiovascular surgery · 2024
    Article
  9. Article
  10. Article
  11. Composition ofFrontiers in cardiovascular medicine · 2023
    Article
  12. Cytokines Removal DuringTransplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Continuous Endogenous Exhaled CO Monitoring by Laser Spectrometer in Human EVLP Before Lung Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2022
    Article
  17. Review
  18. Review
  19. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Anders S I AndreassonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Danai M KaramanouInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Colin S GillespieSchool of Mathematics & Statistics, Newcastle University, Newcastle upon Tyne, UK.
Faruk ÖzalpCardiopulmonary Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, UK.
Tanveer ButtCardiopulmonary Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, UK.
Paul HillCardiopulmonary Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, UK.
Kasim JiwaCardiopulmonary Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, UK.
Hannah R WaldenDepartment of Applied Sciences, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Nicola J GreenInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Lee A BorthwickInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Stephen C ClarkInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Henning PauliCardiopulmonary Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, UK.
Kate F GouldCardiopulmonary Transplantation, Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, UK.
Paul A CorrisInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Simi AliInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
John H DarkInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Andrew J FisherInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

Funding

Department of Health 10/82/01
6 · The paper itself

Abstract

Objectives: Availability of donor lungs suitable for transplant falls short of current demand and contributes to waiting list mortality. Ex vivo lung perfusion (EVLP) offers the opportunity to objectively assess and recondition organs unsuitable for immediate transplant. Identifying robust biomarkers that can stratify donor lungs during EVLP to use or non-use or for specific interventions could further improve its clinical impact. Methods: In this pilot study, 16 consecutive donor lungs unsuitable for immediate transplant were assessed by EVLP. Key inflammatory mediators and tissue injury markers were measured in serial perfusate samples collected hourly and in bronchoalveolar lavage fluid (BALF) collected before and after EVLP. Levels were compared between donor lungs that met criteria for transplant and those that did not. Results: Seven of the 16 donor lungs (44%) improved during EVLP and were transplanted with uniformly good outcomes. Tissue and vascular injury markers lactate dehydrogenase, HMGB-1 and Syndecan-1 were significantly lower in perfusate from transplanted lungs. A model combining IL-1β and IL-8 concentrations in perfusate could predict final EVLP outcome after 2 h assessment. In addition, perfusate IL-1β concentrations showed an inverse correlation to recipient oxygenation 24 h post-transplant. Conclusions: This study confirms the feasibility of using inflammation and tissue injury markers in perfusate and BALF to identify donor lungs most likely to improve for successful transplant during clinical EVLP. These results support examining this issue in a larger study.

Indexed as

AdolescentAdultBiomarkersBronchoalveolar Lavage FluidFeasibility StudiesFemaleHumansInflammation MediatorsLung TransplantationMaleMiddle AgedOrgan PreservationOrgan Preservation SolutionsPerfusionPilot ProjectsPrognosisBiomarkersInflammation MediatorsOrgan Preservation SolutionsBiomarkersEVLPInflammationLung injuryLung transplant

Identifiers

PMID28082471
PMCPMC5400024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.